Xillix Technologies Corp

XLX-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about XLX-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
June 21, 2006
Small market cap of $15 million. Sales have not been as good as expected. Expected loss of $.04 in earnings in 2007.
Show full opinionHide full opinion
Small market cap of $15 million. Sales have not been as good as expected. Expected loss of $.04 in earnings in 2007.
DON'T BUY
DON'T BUY
December 8, 2005
Have got approval from FDA. Estimates have gone down the last 90 days because they hired a large sales staff, but sales are not appearing as quickly as hoped. Earnings are expected to get better for Dec/06, but are still negative going from -$0.08 to -$0.05. Looking out to ’07, they are expecting to earn $0.01.
Show full opinionHide full opinion
Have got approval from FDA. Estimates have gone down the last 90 days because they hired a large sales staff, but sales are not appearing as quickly as hoped. Earnings are expected to get better for Dec/06, but are still negative going from -$0.08 to -$0.05. Looking out to ’07, they are expecting to earn $0.01.
DON'T BUY
DON'T BUY
October 27, 2005
Has interesting technology that uses flourescent lighting to look inside the lungs re: early stage cancer. Ranks 678 out of 700 in the database, the bottom 10%. The market is waiting for sales to appear.
Show full opinionHide full opinion
Has interesting technology that uses flourescent lighting to look inside the lungs re: early stage cancer. Ranks 678 out of 700 in the database, the bottom 10%. The market is waiting for sales to appear.
WAIT
WAIT
July 21, 2005
Have the FDA approval. The challenge in the recent quarter is that sales have been almost non-existant. Now ramping up their sales force which will be an increase in expenses. An excellent product, but a "wait and see" stock. Earnings may take a year, if not longer.
Show full opinionHide full opinion
Have the FDA approval. The challenge in the recent quarter is that sales have been almost non-existant. Now ramping up their sales force which will be an increase in expenses. An excellent product, but a "wait and see" stock. Earnings may take a year, if not longer.
VAGUE
VAGUE
May 18, 2005
Waiting for the FDA approval and are fairly confidant they are going to get it. Just signed a marketing agreement with Conmed (CNMD-Q) which is an expert on high tech medical equipment. These 2 things should be a great impetus to put this company considerably higher.
Show full opinionHide full opinion
Waiting for the FDA approval and are fairly confidant they are going to get it. Just signed a marketing agreement with Conmed (CNMD-Q) which is an expert on high tech medical equipment. These 2 things should be a great impetus to put this company considerably higher.
DON'T BUY
DON'T BUY
April 14, 2005
Did a financing and have some cash. Earnings estimates are for losses, $0.06 in 2005 and $0.02 in 2006. Estimates have been shaved down by about 10% in the last 90 days. Next earnings are due to be reported in 2 weeks. Great product, but still waiting for approval.
Show full opinionHide full opinion
Did a financing and have some cash. Earnings estimates are for losses, $0.06 in 2005 and $0.02 in 2006. Estimates have been shaved down by about 10% in the last 90 days. Next earnings are due to be reported in 2 weeks. Great product, but still waiting for approval.
BUY
BUY
March 23, 2005
Have a product for finding colon/lung cancer. The innovation in terms of product will be adopted by the industry.
Show full opinionHide full opinion
Have a product for finding colon/lung cancer. The innovation in terms of product will be adopted by the industry.
HOLD
HOLD
March 14, 2005
Hoping to get the FDA pre-market approval very soon and will be able to offer their flourescent device for early lung cancer detection. Interesting speculation.
Show full opinionHide full opinion
Hoping to get the FDA pre-market approval very soon and will be able to offer their flourescent device for early lung cancer detection. Interesting speculation.
WAIT
WAIT
February 11, 2005
Interesting technology. They use white light, which is the conventional lighting, for looking inside the body, but also their proprietory flourescent lighting. The challenge is that the company is expected to burn a bunch of cash. Will wait for the sales to start and earnings start to turn.
Show full opinionHide full opinion
Interesting technology. They use white light, which is the conventional lighting, for looking inside the body, but also their proprietory flourescent lighting. The challenge is that the company is expected to burn a bunch of cash. Will wait for the sales to start and earnings start to turn.
BUY WEAKNESS
BUY WEAKNESS
January 13, 2005
Sold his position for tax loss reasons in December. Would like to get back in at around $0.70/0.75. A terrific company. Likes their technology. If they get FDA approval, he would expect a price of $1.85/2.00 in 12/24 months.
Show full opinionHide full opinion
Sold his position for tax loss reasons in December. Would like to get back in at around $0.70/0.75. A terrific company. Likes their technology. If they get FDA approval, he would expect a price of $1.85/2.00 in 12/24 months.
HOLD
HOLD
November 16, 2004
FDA gave a pass to proceed with the testing of Onco-Life, so not sure why the stock has not moved. Still likes.
Show full opinionHide full opinion
FDA gave a pass to proceed with the testing of Onco-Life, so not sure why the stock has not moved. Still likes.
VAGUE
VAGUE
September 2, 2004
It is special and interesting stock.
Show full opinionHide full opinion
It is special and interesting stock.
DON'T BUY
DON'T BUY
August 20, 2004
Has interesting technology. Ranks borderline 25% bottom part of the database. Earnings loss of $.11 improved to a loss of $.07 in 04 and $.02 for 05. Wait for FDA approval.
Show full opinionHide full opinion
Has interesting technology. Ranks borderline 25% bottom part of the database. Earnings loss of $.11 improved to a loss of $.07 in 04 and $.02 for 05. Wait for FDA approval.
WEAK BUY
WEAK BUY
July 9, 2004
Intermediate buy signal. Has interesting technologies. Speculative.
Show full opinionHide full opinion
Intermediate buy signal. Has interesting technologies. Speculative.
BUY
BUY
June 30, 2004
Expect there will be some news out in the next 3/6 months. Good technology. A viable business.
Show full opinionHide full opinion
Expect there will be some news out in the next 3/6 months. Good technology. A viable business.
Showing 1 to 15 of 28 entries

Xillix Technologies Corp(XLX-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Xillix Technologies Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Xillix Technologies Corp(XLX-T) Frequently Asked Questions

What is Xillix Technologies Corp stock symbol?

Xillix Technologies Corp is a OTC stock, trading under the symbol XLX-T on the (). It is usually referred to as or XLX-T

Is Xillix Technologies Corp a buy or a sell?

In the last year, there was no coverage of Xillix Technologies Corp published on Stockchase.

Is Xillix Technologies Corp a good investment or a top pick?

Xillix Technologies Corp was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Xillix Technologies Corp.

Why is Xillix Technologies Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Xillix Technologies Corp worth watching?

In the last year 0 stock analyst on Stockchase covered Xillix Technologies Corp. The stock is worth watching.

What is Xillix Technologies Corp stock price?

On , Xillix Technologies Corp (XLX-T) stock closed at a price of $.